Increased sensitivity to bradykinin among African Americans

Journal of Allergy and Clinical Immunology

Volumn 98, Issue 2, 1996, Pages 283-287

  Gainer, James V ^a,b   Nadeau, John H ^a   Ryder, Diane ^a   Brown, Nancy J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

ACE inhibitor; angioedema; Bradykinin; hypertension; intradermal; kininase II; race; wheat

Indexed keywords

BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERTENSION; KALLIKREIN KININ SYSTEM; MALE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; SKIN TEST; URTICARIA;

EID: 0029813347     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70151-3     Document Type: Article

References (34)

1. Megerian C, Arnold J, Berger M. Angioedema: 5 years' experience, with a review of the disorder's presentation and treatment. Laryngoscope 1992;102:256-60.
2. Schapira M, Silver L, Scott C, et al. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. N Engl J Med 1983;308:1050-4.
3. 2 and in support of "spontaneous" formation of bradykinin. J Allergy Clin Immunol 1983;72:54-60.
4. Schulman G, Hakim R, Arias R, Silverberg M, Kaplan A, Arbeit L. Bradykinin generation by dialysis membranes: possible role in anaphylactic reaction. J Am Soc Nephrol 1993;3:1563-9.
5. Davidson D, Peart I, Turner S, Sangster M. Prevention with icatibant of anaphylactoid reactions to ACE inhibitor during LDL apheresis. Lancet 1994;343:1575.
6. Brown N, Ray W, Snowden M, Griffin M. African Americans have an increased rate of ACEI-associated angioedema. Clin Pharmacol Ther (in press).
7. Levy S, Lilley J, Frigon R, Stone R. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. J Clin Invest 1977;60:129-38.
8. Ferner R, Simpson J, Rawlins M. Effects of intradermal bradykinin after inhibition of angiotensin-converting enzyme. BMJ 1987;294:1119-20.
9. Ferner R, Wilson D, Paterson J, Wilinson R, Rawlins M. The effects of intradermal bradykinin are potentiated by angiotensin converting enzyme inhibitors in hypertensive patients. Br J Clin Pharmacol 1989;27:337-42.
10. Wa T, Cooke E, Turner P. Effects of selective histamine receptor antagonists on skin responses to intradermal bradykinin in health volunteers. J Pharm Pharmacol 1992;44:869-72.
11. McAlpine L, Thomson N. The effect of indomethacin and enalapril on the cutaneous response to bradykinin. Br J Clin Pharmacol 1989;27:870-2.
12. Wa T, Cooke E, Turner P. Cutaneous blood flow changes and weal induced by intradermal bradykinin following pretreatment with indomethacin and captopril. Eur J Clin Pharmacol 1993;44:41-5.
13. Ferner R, Kamali F, Rawlins D. The effect of sulindac on dermal responses to bradykinin in normal subjects given an angiotensin converting enzyme inhibitor. Br J Clin Pharmacol 1990;29:363-5.
14. Raja S, Campbell J, Meyer R, Colman R. Role of kinins in pain and hyperalgesia: psychophysical studies in a patient with kininogen deficiency. Clin Sci 1992;83:337-41.
15. Basran G, Morley J, Paul W, Turner-Warwick M. Evidence in man of synergistic interaction between putative mediators of acute inflammation and asthma. Lancet 1982;1:935-7.
16. Manning D, Raja S, Meyer R, Campbell J. Pain and hyperalgesia after intradermal injection of bradykinin in humans. Clin Pharmacol Ther 1991;50:721-9.
17. 9]-bradykinin in nonatopic and atopic volunteers. J Allergy Clin Immunol 1993;92:683-9.
18. Fuller R, Warren J, McCusker M, Dollery C. Effect of enalapril on the skin response to bradykinin in man. Br J Clin Pharmacol 1987;23:88-90.
19. Anderson M, deShazo R. Studies of the mechanism of angiotensin converting enzyme (ACE) inhibitor-associated angioedema: the effect of an ACE inhibitor on cutaneous responses to bradykinin, codeine, and histamine. J Allergy Clin Immunol 1990;85:856-8.
20. Wa T, Almon N, Cooke E, Turner P. Effect of captopril on skin blood flow following intradermal bradykinin measured by laser Doppler flowmetry. Eur J Clin Pharmacol 1989;37:471-5.
21. Wa T, Cooke E, Turner P. A comparison of the effects of captopril and enalapril on skin responses to intradermal bradykinin and skin blood flow in the human forearm. Br J Clin Pharmacol 1993;35:8-13.
22. Warren J, Newman C, Pixley F, Fuller R, Dollery C. The importance of bradykinin and histamine in the skin response to antigen. Br J Clin Pharmacol 1988;26:803-5.
23. Crossman D, Fuller R. Bradykinin induced wheal and flare is not mediated by histamine release or cyclooxygenase products. Br J Clin Pharmacol 1988;26:113-5.
24. Crimi N, Polosa R, Maccarrone C, Palermo B, Palermo F, Mistretta A. Effect of topical application with capsaicin on skin responses to bradykinin and histamine in man. Clin Exp Allergy 1992;22:933-9.
25. Wallengren J, Håkanson R. Effects of capsaicin, bradykinin and prostaglandin E2 in the human skin. Br J Dermatol 1992;126:111-7.
26. Hall J. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol Ther 1992;56:131-90.
27. Margolius H. Urinary kallikreins and prostaglandins in blacks. J Clin Hypertens 1987;3:51S-56S.
28. Weir M, Gray J, Paster R, Saunders E, for the Trandolapril Multicenter Study Group. Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. Hypertension 1995;25:124-30.
29. Roscher A, Klier C, Dengler R, Faubner A, Müller-Esterl W. Regulation of bradykinin action at the receptor level. J Cardiovasc Pharmacol 1990;15(suppl 6):S39-43.
30. 2-kinin-binding sites in two-kidney, one-clip hypertensive rats. Am J Physiol 1991;260:F626-F634.
31. Elliot R, Nuzum F. Urinary excretion of a depressor substance (kallikrein of Frey and Kraul) in arterial hypertension. Endocrinology 1934;18:462-74.
32. Woodley-Miller C, Chao J, Chao L. Restriction fragment length polymorphisms mapped in spontaneously hypertensive rats using kallikrein probes. J Hypertens 1989;7:865-71.
33. Williams R, Hunt S, Hasstedt S, et al. Definition of genetic factors in hypertension: a search for major genes, polygenes, and homogeneous subtypes. J Cardiovasc Pharmacol 1988;12(suppl 3):S7-S20.
34. Overlack A, Shimpe KO, Kolloch R, Ressel C, Krueck F. Anti-hypertensive effect of orally administered glandular kallikrein in essential hypertension: results of double-blind study. Hypertension 1981;3(suppl I):I-18-I-21.